Effect of pressure overload on cardioprotection of mitochondrial K ATP channels and GSK-3β: Interaction with the MPT pore

American Journal of Hypertension

Volumn 21, Issue 5, 2008, Pages 570-575

  Mozaffari, Mahmood S ^a,b   Schaffer, Stephen W ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; ADENOSINE TRIPHOSPHATE; CYCLOSPORIN A; DIAZOXIDE; GLIBENCLAMIDE; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM CHLORIDE; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG ANTAGONISM; DRUG EFFECT; ENZYME INHIBITION; FLOW RATE; HEART FUNCTION; HEART INFARCTION; HEART PROTECTION; HEART VENTRICLE OVERLOAD; HEART VENTRICLE PRESSURE; MALE; MITOCHONDRIAL PERMEABILITY; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT;

ANIMALS; CARDIOTONIC AGENTS; CYCLOSPORINE; DIAZOXIDE; DISEASE MODELS, ANIMAL; GLYBURIDE; GLYCOGEN SYNTHASE KINASE 3; HYPERTENSION; INDOLES; LITHIUM CHLORIDE; MALE; MALEIMIDES; MITOCHONDRIA, HEART; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PERFUSION; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 42549138502     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2008.25     Document Type: Article

References (29)

1. 2+ channel. Hypertension 2006; 47:912-919.
2. Mozaffari MS, Schaffer SW. Effect of hypertension and hypertension-glucose intolerance on myocardial ischemic injury. Hypertension 2003; 42:1042-1049.
3. Gross GJ, Auchampach JA. Reperfusion injury: does it exist? J Mol Cell Cardiol 2007; 42:12-18.
4. Hausenloy DJ, Yellon DM. Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res 2006; 70:240-253.
5. Matsui T, Rosenzweig A. Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt. J Mol Cell Cardiol 2005; 38:63-71.
6. 1-ATPase inactivation. Am J Physiol 2007; 293:H2056-H2063.
7. Halestrap AP, Clarke SJ, Javadov SZ. Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioprotection. Cardiovasc Res 2004; 61:372-385.
8. Di Lisa F, Bernardi P. Mitochondria and ischemia - reperfusion injury of the heart: fixing a hole. Cardiovasc Res 2006; 70:191-199.
9. Suleiman MS, Halestrap AP, Griffiths EJ. Mitochondria: a target for myocardial protection. Pharmacol Ther 2001; 89:29-46.
10. Tsujimoto Y, Nakagawa T, Shimizu S. Mitochondrial membrane permeability transition and cell death. Biochim Biophys Acta 2006; 1757:1297-1300.
11. Juhaszova M, Zorov DB, Kim S-H, Pepe S, Fu Q, Fishbein KW, Ziman BD, Wang S, Ytrehus K, Antos CL, Olson EN, Sollott SJ. Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 2004; 113:1535-1549.
12. Shalbuyeva N, Brustovetsky T, Brustovestsky N. Lithium desensitizes brain mitochondria to calcium, antagonizes permeability transition and diminishes cytochrome C release. J Biol Chem 2007; 282:18057-18068.
13. 2 inhibit the mitochondrial permeability transition. J Biol Chem 2006; 281:20801-20808.
14. Grover GJ, Garlid KD. ATP-sensitive potassium channels: a review of their cardioprotective pharmacology. J Mol Cell Cardiol 2000; 32:677-695.
15. + channel openers prevent Ca2+ overload in rat cardiac mitochondria. J Physiol 1999; 519:347-360.
16. Mocanu MM, Gadgil S, Yellon DM, Baxter GF. Mibefradil, a T-type and L-type calcium channel blocker, limits infarct size through a glibenclamide-sensitive mechanism. Cardiovasc Drugs Ther 1999; 13:115-122.
17. Skrzypiec-Spring M, Grotthus B, Szelag A, Schulz R. Isolated heart perfusion according to Langendorff-Still viable in the new millennium. J Pharmacol Toxicol Methods 2007; 52:113-126.
18. Korge P, Honda HM, Weiss JN. Protection of cardiac mitochondria by diazoxide and protein kinase C: implications for ischemic preconditioning. Proc Natl Acad Sci USA 2002; 99:3312-3317.
19. Pasdois P, Beauvoit B, Costa ADT, Vinassa B, Tariosse L, Bonoron-Adele S, Garlid KD, Dos Santos P. Sarcoplasmic ATP-sensitive potassium channel blocker HMR1098 protects the ischemic heart: Implications of calcium, complex I, reactive oxygen species and mitochondrial ATP-sensitive potassium channel. J Mol Cell Cardiol 2007; 42:631-642.
20. Pastorino JG, Hoek JB, Shulga N. Activation of glycogen synthase kinase 3β disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity. Cancer Res 2005; 65:10545-10554.
21. Linseman DA, Butts BD, Precht TA, Phelps RA, Le SS, Laessiq TA, Bouchard RJ, Florez-McClure ML, Heidenreich KA. Glycogen synthase kinase 3β phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis. J Neurosci 2004; 24:9993-10002.
22. Nakamura M, Wang N-P, Zhao Z-Q, Wilcox JN, Thourani V, Guyton RA, Vinten-Johansen J. Preconditioning decreases Bax expression, PMN accumulation and apoptosis in reperfused rat heart. Cardiovasc Res 2000; 45:661-670.
23. ATP channels in diazoxide-mediated protection in isolated rabbit hearts. Am J Physiol 2001; 280:H246-H255.
24. Skalska J, Debska G, Kunz WS, Szewczyk A. Antidiabetic sulphonylureas activate mitochondrial permeability transition in rat skeletal muscle. Br J Pharmacol 2005; 145:785-791.
25. + antiporter of beef heart mitochondria. J Biol Chem 1991; 266:6518-6523.
26. + pump in human myocardium during recovery from acidosis. Am J Physiol 1989; 256: H256-H264.
27. Sowers JR, Epstein M. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. Hypertension 1995; 26:869-879.
28. Schaffer SW, Tan BH, Mozaffari MS. Effect of glyburide on myocardial metabolism and function. Am J Med 1985; 79(Suppl 3B):48-52.
29. Schaffer SW, Poole CG, Lampson WG, Kramer JH. Effect of tolbutamide on the mechanical function of the isolated rat heart subjected to global ischemia. J Mol Cell Cardiol 1981; 13:341-345.